Emerald Acquisition’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$270K Sell
15,871
-45,083
-74% -$767K ﹤0.01% 2623
2016
Q2
$1.3M Buy
+60,954
New +$1.3M ﹤0.01% 2024